Category Archives: Parkinson’s Treatment

NEW YORK, Feb. 3, 2021 /PRNewswire/ --With the onset of a world health crisis, our seniors are at a greater risk than they were a decade ago Continue reading →

February is kicking off with a number of PDUFA dates for the U.S. Continue reading →

American Heart Month February is American Heart Month. Cardiovascular disease is the leading cause of death in The United States and approximately 1.5 million heart attacks and strokes occur every year. Morethan 800,000 people in the U.S Continue reading →

AstraZenecas COVID-19 vaccine reduced transmission of the virus and appeared to offer protection with one dose, a new study found. The results may support the U.K.s plan to delay second shots. (AP) Jazz Pharmaceuticals announced it will buy GW Pharma for $7.2 billion Continue reading →

The coronavirus pandemic dominated the headlines and our daily lives for most of the past year. Medical News Today have covered this fast-moving, complex story with live updates on the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask. However, this hasnt stopped us from publishing hundreds of fascinating stories on a myriad of other topics Continue reading →

NEW YORK, Feb. 1, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health virtual conference, Wednesday, February 3rd and Thursday, February 4th, 2021. Continue reading →

- First potentially disease-modifying gene therapy for GM2 gangliosidosis to enter clinical studies - Expect to continue patient identification, screening, and enrollment in Stage 1 of the study throughout 2021 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Feb. Continue reading →

-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and neurologist- HOUSTON, Feb Continue reading →

Focused ultrasound for ablation of the subthalamic nucleus in one hemisphere improved motor features in a selected group of patients with markedly asymmetric Parkinson's disease, but was associated with a high rate of adverse events, including dyskinesias and other neurologic complications, in a new randomized sham-controlled trial. "Longer-term and larger trials are needed to determine the role of focused ultrasound subthalamotomy in the management of Parkinson's disease and its effect as compared with other available treatments, including deep-brain stimulation," the authors conclude. Continue reading →

Parkinsons disease, a brain disorder that affects over 10 million people worldwide, is caused by the gradual loss of dopamine neurons. The loss of these neurons leads to involuntary tremors, stiffness and balance problems. While there are drugs to treat these symptoms, no drugs exist to slow the progression of the disease Continue reading →